Item 7.01. Regulation FD Disclosure.
Earlier today, the U.S. District Court for the Northern District of Ohio issued
its abatement ruling in a single, two county trial involving opioids in the
multidistrict litigation. The order provided for injunctive and abatement relief
to the two counties, with the abatement relief from the ruling on a joint and
several liability basis being approximately $651 million in the aggregate to be
paid over 15 years from all of the pharmacy defendants in the litigation (the
"Abatement Amount"), including Walmart Inc. (the "Company"). The court also
ordered the pharmacy defendants to pay immediately into an abatement fund
approximately $87 million of the total Abatement Amount, reflecting the first
two years of abatement. The Company plans to appeal the liability and abatement
rulings in this litigation matter. The Company issued a Corporate Statement
regarding the abatement ruling and this litigation matter. A copy of the
Corporate Statement issued by the Company in response to the ruling is furnished
as Exhibit 99.1 to this report.
In accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report, including Exhibit 99.1, shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise be subject to the liability of that section and shall not be
incorporated by reference into any filing or other document filed under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such filing or document.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Corporate Statement dated August 17, 2022 issued by Walmart related to an abatement
ruling in the Multidistrict Opioids Litigation in the U.S. District Court for the
Northern District of Ohio.
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses